Skip to main content

Haemonetics Corp

HAE
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000313143

In the last 90 days, Haemonetics Corp insiders filed 0 open-market purchases and 1 sale; 332 institutions reported holding it in 13F filings for Q2 2026, worth $3.72B in total; no superinvestor holds it.

Key figures

Market capClose on Nov 13, 2026
$5.60B
Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $101.1K in total
1
13F holdersQ2 2026, +11 vs. previous quarter
332
13F valueReported value at the end of Q2 2026
$3.72B
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2026
$1.33B
−2.0% year over year
Net income, FY2026
$97.3M
−42.0% year over year
Free cash flow, FY2026
$260.4M
+82.8% year over year
Revenue, Q2 FY2027
$357.8M
+9.3% year over year

Revenue flow, FY2026

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
3.60M
Shares sold short
Change
+171.2K
+5.0% vs. previous
Days to cover
6.27
At average daily volume

Superinvestors holding HAE, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding HAE at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Haemonetics Corp insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 13, 2026 (view filing)4:16 PM ETNov 112 daysMaunsell Farris MaryanneVP, Chief Accounting OfficerSSale−836$120.99−$101.1K−12.5%5.83K after
Nov 12, 2025 (view filing)Nov 102 daysKroll Mark WDirectorPPurchase+1.40K$70.56+$98.8K+6.0%24.8K after
Jul 29, 2024 (view filing)Jul 263 daysStrong Stewart WPresident, Global HospitalSSale−4.31K$91.15−$393.0K−19.2%18.2K after10b5-1
Jul 15, 2024 (view filing)Jul 11-124 daysLingamneni AnilaEVP, Chief Technology OfficerSSale−2.21K$90.00−$199.3K−9.4%21.3K after2 lots10b5-1
May 29, 2024 (view filing)May 29Same dayBasil Michelle LEVP and General CounselSSale−13.0K$88.08−$1.14M−29.4%31.3K after2 lots10b5-1
May 29, 2024 (view filing)May 29Same dayStrong Stewart WPresident, Global HospitalSSale−8.86K$87.53−$775.3K−32.7%18.2K after10b5-1
May 21, 2024 (view filing)May 201 dayStrong Stewart WPresident, Global HospitalSSale−686$95.11−$65.2K−3.6%18.2K after10b5-1
May 21, 2024 (view filing)May 17-204 daysLlorens JosepEVP, Global ManufacturingSSale−1.81K$94.96−$171.8K−7.8%21.3K after2 lots10b5-1
May 21, 2024 (view filing)May 17-204 daysBasil Michelle LEVP and General CounselSSale−2.68K$95.05−$254.4K−7.9%31.3K after2 lots10b5-1
May 17, 2024 (view filing)May 161 dayStrong Stewart WPresident, Global HospitalSSale−733$96.04−$70.4K−4.5%15.6K after10b5-1

Top 10 13F holders, Q2 2026

See all 332 holders

The largest institutional positions in Haemonetics Corp at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding HAE in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.5,909,258$443.2M0.01%+289,279+5.1%Added
Neuberger Berman Group LLC4,179,443$313.5M0.21%+618,525+17.4%Added
Vanguard Portfolio Management LLC2,546,394$191.0M0.01%−12,922−0.5%Reduced
AQR Capital Management LLC2,266,489$165.0M0.06%−1,090,054−32.5%Reduced
Ariel Investments, LLC2,060,966$154.6M1.54%+2,060,966New
Vanguard Capital Management LLC2,059,578$154.5M0.00%−30,811−1.5%Reduced
State Street Corp1,818,186$136.4M0.00%+45,288+2.6%Added
Dimensional Fund Advisors LP1,585,222$118.9M0.02%+259,165+19.5%Added
Citadel Advisors LLC1,510,120$113.3M0.07%+1,251,967+485.0%Added
Geode Capital Management, LLC1,287,240$96.6M0.01%+68,262+5.6%Added

Holders of 5% or more of HAE

See all 2 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Haemonetics Corp.

Largest holders of HAE from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Vanguard Portfolio Management LLC13G5.59%2.60M sharesNewApr 29, 20261 filingApr 29, 2026SEC
Vanguard Capital Management LLC13G5.26%2.45M sharesNewApr 30, 20261 filingApr 30, 2026SEC

3 members of Congress reported 10 trades in Haemonetics Corp since 2020. Newest filings:

  1. Lois Frankel

    House · FL · May 25, 2021

    Sell$1K-$15K

  2. Lois Frankel

    House · FL · May 25, 2021

    Sell (partial)$1K-$15K

  3. Josh Gottheimer

    House · NJ · Feb 9, 2021

    Sell$1K-$15K

  4. Josh Gottheimer

    House · NJ · Nov 5, 2020

    Buy$1K-$15K

  5. Josh Gottheimer

    House · NJ · Oct 13, 2020

    Sell (partial)$1K-$15K